140 related articles for article (PubMed ID: 38183655)
1. Protocol for quantification of UDP-GlcNAc using an enzymatic microplate assay.
Upadhyay D; Banerjee R; Kallijärvi J; Purhonen J
STAR Protoc; 2024 Mar; 5(1):102817. PubMed ID: 38183655
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
3. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
4. Impaired O-linked N-acetylglucosaminylation in the endoplasmic reticulum by mutated epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase found in Adams-Oliver syndrome.
Ogawa M; Sawaguchi S; Kawai T; Nadano D; Matsuda T; Yagi H; Kato K; Furukawa K; Okajima T
J Biol Chem; 2015 Jan; 290(4):2137-49. PubMed ID: 25488668
[TBL] [Abstract][Full Text] [Related]
5. Efficient chemoenzymatic synthesis of uridine 5'-diphosphate N-acetylglucosamine and uridine 5'-diphosphate N-trifluoacetyl glucosamine with three recombinant enzymes.
Li X; Qi C; Wei P; Huang L; Cai J; Xu Z
Prep Biochem Biotechnol; 2017 Oct; 47(9):852-859. PubMed ID: 27220687
[TBL] [Abstract][Full Text] [Related]
6. Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc.
Lefebvre T; Drougat L; Olivier-Van Stichelen S; Michalski JC; Vercoutter-Edouart AS
Methods Mol Biol; 2013; 1022():147-59. PubMed ID: 23765660
[TBL] [Abstract][Full Text] [Related]
7. Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models.
Issad T; Al-Mukh H; Bouaboud A; Pagesy P
J Biomed Sci; 2022 Sep; 29(1):64. PubMed ID: 36058931
[TBL] [Abstract][Full Text] [Related]
8. A nexus of lipid and
Lockridge A; Hanover JA
Front Endocrinol (Lausanne); 2022; 13():943576. PubMed ID: 36111295
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-based assay for quantification of UDP-GlcNAc in cells and tissues.
Chatham JC; Ha CM; Wende AR
Cell Rep Methods; 2023 Jul; 3(7):100537. PubMed ID: 37533649
[TBL] [Abstract][Full Text] [Related]
10. Protein O-GlcNAcylation impairment caused by N-acetylglucosamine phosphate mutase deficiency leads to growth variations in Arabidopsis thaliana.
Jia X; Zhang H; Qin H; Li K; Liu X; Wang W; Ye M; Yin H
Plant J; 2023 May; 114(3):613-635. PubMed ID: 36799458
[TBL] [Abstract][Full Text] [Related]
11. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
Le Minh G; Reginato MJ
Adv Cancer Res; 2023; 157():195-228. PubMed ID: 36725109
[TBL] [Abstract][Full Text] [Related]
12. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
13. Novel acetylation-aided migrating rearrangement of uridine-diphosphate-N-acetylglucosamine in electrospray ionization multistage tandem mass spectrometry.
Liu HD; Li YM; Du JT; Hu J; Zhao YF
J Mass Spectrom; 2006 Feb; 41(2):208-15. PubMed ID: 16382487
[TBL] [Abstract][Full Text] [Related]
14. Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.
Vigetti D; Deleonibus S; Moretto P; Karousou E; Viola M; Bartolini B; Hascall VC; Tammi M; De Luca G; Passi A
J Biol Chem; 2012 Oct; 287(42):35544-35555. PubMed ID: 22887999
[TBL] [Abstract][Full Text] [Related]
15. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
Packer M
Eur J Heart Fail; 2023 Aug; 25(8):1199-1212. PubMed ID: 37434410
[TBL] [Abstract][Full Text] [Related]
16. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.
Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N
Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074
[TBL] [Abstract][Full Text] [Related]
17. Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Chatham JC; Young ME; Zhang J
Curr Opin Pharmacol; 2021 Apr; 57():1-12. PubMed ID: 32937226
[TBL] [Abstract][Full Text] [Related]
18. Uridine diphosphate release mechanism in O-N-acetylglucosamine (O-GlcNAc) transferase catalysis.
She N; Zhao Y; Hao J; Xie S; Wang C
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):609-622. PubMed ID: 30550897
[TBL] [Abstract][Full Text] [Related]
19. Reprint of: Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Chatham JC; Young ME; Zhang J
Curr Opin Pharmacol; 2020 Oct; 54():209-220. PubMed ID: 33278716
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
